Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
InnoCare to Attend Upcoming Investor Conferences to Share Latest Company Development 2021-11-12 14:14
The New Era Biotechnology deepens cooperation between China and Belarus in the Great Stone China Belarus Industrial Park (CBIP) 2021-11-12 09:11
Hetero and Shenzhen Beimei Pharmaceuticals launch antiviral drug Oselavir® in China 2021-11-12 09:00
Recbio Announces Promising Preliminary Results From First-in-Human Study of a COVID-19 Vaccine Candidate With Novel Adjuvant BFA03 2021-11-12 07:55
PNOC Study in Childhood Brain Cancer Enrols First Patient 2021-11-11 21:00
Gmax's GMA106, second generation obesity/T2DM/NASH mAb gives first in human dose 2021-11-11 18:00
Everest Medicines and Gilead Sciences Jointly Announce Phase 2b Study of Sacituzumab Govitecan Conducted in China of Patients With Metastatic Triple-negative Breast Cancer Meets Primary Overall Response Rate Endpoint 2021-11-11 08:05
Recruitment for the dosimetry phase of Clarity's Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial completed 2021-11-10 22:06
IASO Biotherapeutics and Innovent Biologics to Present New BCMA CAR-T Cell Therapy Data in Oral Presentation at ASH 2021 2021-11-10 21:30
I-Mab and Jumpcan Announce Strategic Commercial Partnership on Eftansomatropin Alfa 2021-11-10 17:30
Hummingbird Bioscience Announces Trials in Progress Poster Presentation at the Society for Immunotherapy of Cancer 2021 36th Annual Meeting 2021-11-10 17:00
Ascletis Announces Approval of Phase II Clinical Trial of ASC22 (Envafolimab) by China NMPA for Immune Restoration/Functional Cure of HIV-1 Infected Patients 2021-11-10 08:30
I-Mab and ABL Bio Report Preclinical Data of 4-1BB-targeting Bispecific Antibodies at 2021 SITC 2021-11-09 21:05
INOVIO Receives U.S. FDA Authorization to Proceed with INNOVATE Phase 3 Segment for its COVID-19 Vaccine Candidate, INO-4800, in the U.S. 2021-11-09 21:00
Alterity Therapeutics Announces Presentation of ATH434 at the American Autonomic Society Virtual Meeting 2021 2021-11-09 20:30
FDA Clears Pharmaxis Cancer Drug to Progress to Phase 2 Study in Liver Cancer 2021-11-09 19:00
Antengene to Release Preliminary Results of Selinexor for the Treatment of Peripheral T-Cell Lymphoma and NK/T-Cell Lymphoma at the 2021 ASH Annual Meeting 2021-11-09 16:30
Standigm Established a Synthetic Research Center to Improve Efficiency of AI Drug Discovery 2021-11-09 10:47
Recbio Announces New Study Showing Its COVID-19 Vaccine Induced High Levels of Neutralizing Antibodies against SARS-CoV-2 and Variants of Concern 2021-11-09 10:00
Sustained Hepatitis B Surface Antigen Loss in Chronic Hepatitis B Patients with Subcutaneous PD-L1 Antibody ASC22 Treatment: Interim Results of Phase IIb Study 2021-11-09 08:33
1 212 213 214 215 216 413